Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxone SR in Opioid Induced Constipation
NCT00984334Phase 2Completed
- Sponsor
- SLA Pharma
- Start
- Oct 2009
- Primary completion
- Jan 2012
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of naloxone in opioid-induced constipation (OIC), sponsored by SLA Pharma. Started Oct 2009; status: completed.
02
Drugs
naloxone
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT00984334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00984334.